Article Details

BioInvent presents new preclinical data on BI-1808, a first-in-class anti-TNFR2 antibody at the SITC ...

Retrieved on: 2020-11-08 21:52:30

Tags for this article:

Click the tags to see associated articles and topics

BioInvent presents new preclinical data on BI-1808, a first-in-class anti-TNFR2 antibody at the SITC .... View article details on hiswai:

Excerpt

<div>... of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today presents new data on BI-1808, a <b>monoclonal antibody</b> to ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up